Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide

BACKGROUND: Cancer vaccines aim at eliciting not only an immune response against specific tumor antigens, but also at enhancing a preexisting immunity against the tumor. In this context, we recently reported on the levels of preexisting immunity in prostate cancer patients vaccinated with the HER-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Voutsas, Ioannis F., Anastasopoulou, Eleftheria A., Tzonis, Panagiotis, Papamichail, Michael, Perez, Sonia A., Baxevanis, Constantin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109671/
https://www.ncbi.nlm.nih.gov/pubmed/27891225
http://dx.doi.org/10.1186/s40425-016-0183-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109671/
https://www.ncbi.nlm.nih.gov/pubmed/27891225
http://dx.doi.org/10.1186/s40425-016-0183-4

Ejemplares similares